Currently holds a position at Albireo Pharma Inc
Position | Company | Period |
---|---|---|
Chief Regulatory Officer | Albireo Pharma Inc | Nov. 1, 2016 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-01-23 | 2023-01-23 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
120
-0.8%
43.805,256 USD |
120 -0.8% | 43.80 | 5,256 USD | |
2023-01-20 | 2023-01-19 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
938
-6.0%
43.9041,182 USD |
938 -6.0% | 43.90 | 41,182 USD | |
2022-10-25 | 2022-10-24 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
104
-0.7%
19.582,036 USD |
104 -0.7% | 19.58 | 2,036 USD | |
2022-07-25 | 2022-07-22 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
106
-0.7%
24.682,616 USD |
106 -0.7% | 24.68 | 2,616 USD | |
2022-04-25 | 2022-04-22 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
103
-0.6%
32.923,391 USD |
103 -0.6% | 32.92 | 3,391 USD | |
2022-01-25 | 2022-01-24 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
423
-2.6%
24.5210,370 USD |
423 -2.6% | 24.52 | 10,370 USD | |
2020-09-15 | 2020-09-11 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
10,000
-100.0%
40.03400,300 USD |
10,000 -100.0% | 40.03 | 400,300 USD | |
2020-09-10 | 2020-09-10 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
10,000
-100.0%
42.41424,100 USD |
10,000 -100.0% | 42.41 | 424,100 USD | |
2020-09-10 | 2020-09-09 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
2,500
-100.0%
39.8299,550 USD |
2,500 -100.0% | 39.82 | 99,550 USD | |
2020-09-10 | 2020-09-09 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
7,500
-75.0%
38.68290,100 USD |
7,500 -75.0% | 38.68 | 290,100 USD | |
2020-09-10 | 2020-09-08 |
Albireo Pharma Inc
(ALBO)
|
PS Planned sale |
10,000
-100.0%
45.55455,500 USD |
10,000 -100.0% | 45.55 | 455,500 USD |